Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0003319721991734 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The relationship between the new inflammatory markers and disease severity in patients with acute coronary syndrome.
Acta Cardiol
September 2024
Department of Cardiology, Acıbadem Adana Hospital, Adana, Turkey.
Background: Inflammation plays a crucial role in the progression of acute coronary syndrome.
Aims: The aim of this study was to investigate the relationship between the SYNTAX score and new inflammatory markers including albumin-globulin ratio (AGR), C-reactive protein-to-albumin ratio (CAR), fibrinogen-to-albumin ratio (FAR), neutrophil-to-albumin ratio (NAR), and neutrophil percentage-to-albumin ratio (NPAR) in STEMI and NSTEMI patients.
Methods: The study involved 53 STEMI and 64 NSTEMI patients, and each patient group was evaluated separately.
CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets.
Front Immunol
July 2024
Department of Medicine, Division of Blood and Bone Marrow Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, CA, United States.
Human regulatory T cells (Treg) suppress other immune cells. Their dysfunction contributes to the pathophysiology of autoimmune diseases, including type 1 diabetes (T1D). Infusion of Tregs is being clinically evaluated as a novel way to prevent or treat T1D.
View Article and Find Full Text PDFC-reactive protein to albumin ratio may predict in-hospital mortality in non-ST elevation myocardial infarction.
Biomark Med
February 2024
Department of Biostatistics, Faculty of Medicine, Aksaray University, Aksaray, Turkey.
The authors investigated the value of novel inflammatory markers, systemic immune-inflammation index and C-reactive protein to albumin ratio (CAR), to predict in-hospital mortality in patients with non-ST elevation myocardial infarction (NSTEMI). A total of 308 patients who underwent percutaneous coronary intervention because of NSTEMI were retrospectively included in the study. Killip classification, Thrombolysis in Myocardial Infarction score, SYNTAX score, and CAR and systemic immune-inflammation index values were calculated.
View Article and Find Full Text PDFHigh CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI.
Medicine (Baltimore)
October 2023
Department of Cardiology, Bilecik Şeyh Edebali University, Bilecik, Turkey.
In patients undergoing primary percutaneous coronary intervention (pPCI) due to ST-segment elevation myocardial infarction (STEMI), an increased intracoronary thrombus burden is a strong predictive factor for adverse cardiovascular events. The C-reactive protein (CRP)-serum albumin (SA) ratio (CAR), used as an inflammatory marker, is closely associated with thrombogenicity. In this study, we investigated the relationship between coronary thrombus burden and CAR in patients undergoing pPCI due to newly diagnosed STEMI.
View Article and Find Full Text PDFPeriprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
Catheter Cardiovasc Interv
August 2023
Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Background: Limited data are available on the risk of periprocedural myocardial infarction (MI) in patients undergoing complex versus noncomplex percutaneous coronary intervention (PCI).
Methods: We assessed the risk of periprocedural MI according to the fourth Universal definition of myocardial infarction (UDMI) and several other criteria among patients undergoing elective PCI in a prospective, single-center registry. Complex PCI included at least one of the following: 3 coronary vessels treated, ≥3 stents implanted, ≥3 lesions treated, bifurcation with 2 stents implanted, total stent length >60 mm, treatment of chronic total occlusion, and use of rotational atherectomy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!